Personalis Stock Analysis

PSNL Stock  USD 5.51  0.52  10.42%   
Personalis is undervalued with Real Value of 6.57 and Hype Value of 5.12. The main objective of Personalis stock analysis is to determine its intrinsic value, which is an estimate of what Personalis is worth, separate from its market price. There are two main types of Personalis' stock analysis: fundamental analysis and technical analysis.
The Personalis stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Personalis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Personalis Stock please use our How to buy in Personalis Stock guide.

Personalis Stock Analysis Notes

About 16.0% of the company outstanding shares are owned by corporate insiders. The book value of Personalis was at this time reported as 2.36. The company has Price/Earnings To Growth (PEG) ratio of 0.09. Personalis recorded a loss per share of 1.73. The entity had not issued any dividends in recent years. Personalis, Inc. operates as a cancer genomics company worldwide. Personalis, Inc. was incorporated in 2011 and is headquartered in Menlo Park, California. Personalis operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 325 people. To find out more about Personalis contact Christopher Hall at 650 752 1300 or learn more at https://www.personalis.com.

Personalis Investment Alerts

Personalis is way too risky over 90 days horizon
Personalis appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 73.48 M. Net Loss for the year was (108.3 M) with profit before overhead, payroll, taxes, and interest of 27.48 M.
Personalis currently holds about 233.49 M in cash with (56.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.09.
Roughly 61.0% of the company shares are owned by institutional investors

Personalis Upcoming and Recent Events

22nd of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Personalis Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 466.66 M.

Personalis Profitablity

The company has Profit Margin (PM) of (1.05) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.56) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.56.

Technical Drivers

As of the 17th of February 2025, Personalis holds the Coefficient Of Variation of 861.6, risk adjusted performance of 0.0913, and Semi Deviation of 4.35. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Personalis, as well as the relationship between them. Please check Personalis information ratio, potential upside, as well as the relationship between the Potential Upside and kurtosis to decide if Personalis is priced some-what accurately, providing market reflects its current price of 5.51 per share. Given that Personalis has jensen alpha of 0.9284, we recommend you to check out Personalis's recent market performance to make sure the company can sustain itself at a future point.

Personalis Price Movement Analysis

Execute Study
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Personalis middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Personalis. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Personalis Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Personalis insiders, such as employees or executives, is commonly permitted as long as it does not rely on Personalis' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Personalis insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Personalis Outstanding Bonds

Personalis issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Personalis uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Personalis bonds can be classified according to their maturity, which is the date when Personalis has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Personalis Predictive Daily Indicators

Personalis intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Personalis stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Personalis Forecast Models

Personalis' time-series forecasting models are one of many Personalis' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Personalis' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Personalis Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Personalis prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Personalis shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Personalis. By using and applying Personalis Stock analysis, traders can create a robust methodology for identifying Personalis entry and exit points for their positions.
Personalis, Inc. operates as a cancer genomics company worldwide. Personalis, Inc. was incorporated in 2011 and is headquartered in Menlo Park, California. Personalis operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 325 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Personalis to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Pair Correlation Now

   

Pair Correlation

Compare performance and examine fundamental relationship between any two equity instruments
All  Next Launch Module
When determining whether Personalis is a strong investment it is important to analyze Personalis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Personalis' future performance. For an informed investment choice regarding Personalis Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Personalis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Personalis Stock please use our How to buy in Personalis Stock guide.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Personalis. If investors know Personalis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Personalis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Personalis is measured differently than its book value, which is the value of Personalis that is recorded on the company's balance sheet. Investors also form their own opinion of Personalis' value that differs from its market value or its book value, called intrinsic value, which is Personalis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Personalis' market value can be influenced by many factors that don't directly affect Personalis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Personalis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Personalis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Personalis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.